id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0021-0008,FDA,FDA-2010-E-0021,"U.S. Patent and Trademark Office to Lundbeck Research USA, Inc. - Letter",Other,Letter(s),2013-05-07T04:00:00Z,2013,5,2013-05-07T04:00:00Z,,2013-05-07T12:53:06Z,,0,0,09000064812bd703
FDA-2010-E-0021-0007,FDA,FDA-2010-E-0021,Notice of Final Determination - Letter,Other,Letter(s),2012-12-17T05:00:00Z,2012,12,2012-12-17T05:00:00Z,,2012-12-17T19:49:57Z,,0,0,090000648118ff3a
FDA-2010-E-0021-0006,FDA,FDA-2010-E-0021,FDA/CDER to US Patent and Trademark Office - Letter,Other,Letter(s),2011-08-17T04:00:00Z,2011,8,2011-08-17T04:00:00Z,,2011-08-17T15:36:07Z,,0,0,0900006480ee32f8
FDA-2010-E-0021-0005,FDA,FDA-2010-E-0021,Determinations of Regulatory Review Periods for Purposes of Patent Extension; SABRIL,Notice,N-Notice,2010-12-09T05:00:00Z,2010,12,2010-12-09T05:00:00Z,,2024-11-07T22:27:57Z,2010-30995,1,0,0900006480bb2d85
FDA-2010-E-0021-0004,FDA,FDA-2010-E-0021,FDA/CDER to U.S. Patent Trademark Office - Letter,Other,LET-Letter,2010-10-28T04:00:00Z,2010,10,2010-10-28T04:00:00Z,,2010-10-28T16:10:14Z,,0,0,0900006480b799ac
FDA-2010-E-0021-0003,FDA,FDA-2010-E-0021,FDA/CDER to the USPTO,Other,LET-Letter,2010-05-11T04:00:00Z,2010,5,2010-05-11T04:00:00Z,,2024-11-12T04:53:31Z,,1,0,0900006480aeb436
FDA-2010-E-0021-0002,FDA,FDA-2010-E-0021,"Lundbeck, Inc. - Patent Term Extension Application",Other,APP-Application,2010-01-12T05:00:00Z,2010,1,2010-01-12T05:00:00Z,,2013-08-11T03:06:15Z,,0,0,0900006480a7ba9e
FDA-2010-E-0021-0001,FDA,FDA-2010-E-0021,U.S. Patent & Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2010-01-12T05:00:00Z,2010,1,2010-01-12T05:00:00Z,,2013-08-11T03:06:15Z,,0,0,0900006480a7ba9c